Lee's work focuses on understanding how cancer interacts with the immune system in order to develop treatments that harness the patient's own immune response to control cancer in a more specific and less toxic way. Lee is also the new chair of the Department of Cancer Immunotherapeutics and Tumor Immunology at City of Hope. His lab has found that the distribution, function, and patterns of immune cells have a strong correlation with clinical outcome.
The Wilder gift also funds the new Wilder Archives Recognition Gallery at City of Hope, which will serve as a visual guide to showcase the past and present generosity of donors since City of Hope's founding in 1913.
Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute is one of 25 organizations in Ohio to receive Magnet designation as part of the American Nurses Credentialing Center's Magnet Recognition Program. The voluntary hospital recognition program is considered the highest honor an organization can receive for quality patient care and professional nursing practice.
Institute of Medicine Names New Members
The Institute of Medicine has named 70 new members and 10 foreign associates this year. Election to the IOM recognizes individuals who have demonstrated outstanding professional achievement and commitment to service among those in the fields of health and medicine.
“These individuals have inspired us through their achievements in research, teaching, clinical work, and other contributions to the medical field,” IOM President Harvey V. Fineberg, MD, PhD, said in a news release.
“Their knowledge and skills will deeply enrich the IOM.”
New members are elected by current active members, and the Institute's charter stipulates that at least one-quarter of the membership be selected from outside of the health professions to ensure a diversity of talent among the membership. Newly elected members from the oncology community include:
* Janis L. Abkowitz, MD, the Clement A. Finch Professor and Head of the Division of Hematology in the Department of Medicine at the University of Washington;
* Frederick R. Appelbaum, MD, Executive Vice President and Deputy Director of Fred Hutchinson Cancer Research Center and President and Executive Director of Seattle Cancer Care Alliance;
* Katrina Alison Armstrong, MD, Physician-in-Chief of Massachusetts General Hospital and the Jackson Professor of Clinical Medicine at Harvard Medical School;
* James R. Downing, MD, Executive Vice President, Scientific Director, and Deputy Director of St. Jude Children's Research Hospital;
* Jeffrey Adam Drebin, MD, PhD, the John Rice Barton Professor and Chairman in the Department of Surgery at the Perelman School of Medicine at the University of Pennsylvania;
* Eric M. Fearon, MD, PhD, the Emanuel N. Maisel Professor of Oncology in the Department of Internal Medicine and Professor of Medicine, both at the University of Michigan;
* Judy E. Garber, MD, MPH, Director of the Center for Cancer Genetics and Prevention at Dana-Farber Cancer Institute's Susan F. Smith Center for Women's Cancers;
* Waun Ki Hong, MD, Division Head and Professor, an American Cancer Society Professor, and a Samsung Distinguished University Chair in Cancer Medicine, at the University of Texas MD Anderson Cancer Center;
* Clifford R. Jack Jr., MD, Professor of Radiology and Diagnostic Radiology at Mayo Clinic;
* Richard Kolodner, MD, Member and Professor of the Ludwig Institute for Cancer Research at the University of California San Diego;
* Sally Kornbluth, PhD, the James B. Duke Professor of Pharmacology and Cancer Biology and Vice Dean for Basic Science in the School of Medicine at Duke University;
* Quynh Thu Xuan Le, MD, Chairman and Professor in the Department of Radiation Oncology at Stanford University;
* Ruslan Medzhitov, PhD, a Howard Hughes Medical Institute Investigator and David W. Wallace Professor of Immunobiology at Yale University School of Medicine;
* Joan M. O'Brien, MD, the William F. Norris and George E. de Schweintz Professor and Chairman in the Department of Ophthalmology and Director of the Scheie Eye Institute at the Perelman School of Medicine at the University of Pennsylvania;
* Helen Piwnica-Worms, PhD, Vice Provost for Science and Professor of Cancer Biology at the University of Texas MD Anderson Cancer Center;
* J. Evan Sadler, MD, PhD, Professor of Medicine in the Department of Medicine at Washington University School of Medicine in St. Louis; and
* George M. Shaw, MD, PhD, Professor of Medicine in the Division of Hematology/Oncology at the Perelman School of Medicine at the University of Pennsylvania.
Newly elected foreign associates from the oncology community include:
* Patrick Couvreur, PhD, PharmD, Professor at the Institut Galient at the University of Paris-Sud;
* Daiming Fan, MD, PhD, Vice President of the Chinese Academy of Engineering in Beijing and Professor and Director of Xijing Hospital of Digestive Diseases at the Fourth Military Medical University in Xi'an, China;
* Moshe Oren, PhD, Professor of Molecular Cell Biology at the Weizmann Institute of Science in Rehovot, Israel; and
* Xiaoming Shen, MD, PhD, Professor of Pediatrics at Xin Hua Hospital and Shanghai Children's Medical Center at Shanghai Jiao Tong University School of Medicine in China.
ASH Elects New Executive Committee Members
The American Society of Hematology has elected three new members to its Executive Committee, who will begin terms after this year's Annual Meeting:
* Charles S. Abrams, MD, Director of the University of Pennsylvania School of Medicine and Children's Hospital of Philadelphia Blood Center for Patient Care & Discovery and Associate Chief of Hematology/Oncology at the University of Pennsylvania, will serve a one-year term as Vice President, followed by successive terms as President-Elect and President. Abrams has been active in mentoring young hematologists and developing continuing medical education programs in clinical hematology, and previously served a four-year term as ASH Secretary (2009 to 2012).
* Michelle Le Beau, PhD, Director of the University of Chicago Comprehensive Cancer Center and the University of Chicago Cancer Cytogenetics Laboratory and the Arthur and Marian Edelstein Professor of Hematology/Oncology at the University of Chicago, will serve a four-year term as councillor.
* Martin S. Tallman, MD, Chief of the Leukemia Service at Memorial Sloan-Kettering Cancer Center and Professor of Medicine at Weill Cornell Medical College, will also serve a four-year term as councillor.
Share Your News!
Send information and photos for this column to OT@LWWNY.com© 2013 by Lippincott Williams & Wilkins, Inc.
More on ONCOLOGY-TIMES.com...